In-flight flow visualization with pressure measurements at low speeds on the NASA F-18 high alpha research vehicle

In-flight results from surface and off-surface flow visualizations and from extensive pressure distributions document the vortical flow on the leading edge extensions (LEX) and forebody of the NASA F-18 high alpha research vehicle for low speeds and angles of attack up to 50 degs. Surface flow visualization data, obtained using the emitted fluid technique, were used to define separation lines and laminar separation bubbles. Off-surface flow visualization data, obtained by smoke injection, were used to document both the path of the vortex cores and the location of vortex core breakdown. The location of vortex core breakdown correlated well with the loss of suction pressure on the LEX and with the flow visualization results from ground facilities. Surface flow separation lines on the LEX and forebody corresponded well with the end of pressure recovery under the vortical flows. Correlation of the pressures with wind tunnel results show fair to good correlation

Summary of in-flight flow visualization obtained from the NASA high alpha research vehicle

A summary of the surface and off-surface flow visualization results obtained in flight on the F-18 high alpha research vehicle (HARV) is presented, highlighting the extensive 3-D vortical flow on the aircraft at angles of attack up to 50 degs. The emitted fluid technique, as well as tufts and flow cones, were used to document the surface flow. A smoke generator system injected smoke into the vortex cores generated by the forebody and leading edge extensions (LEXs). Documentation was provided by onboard still and video, by air-to-air, and by postflight photography. The surface flow visualization techniques revealed laminar separation bubbles near the forebody apex, lines of separation on the forebody and LEX, and regions of attached and separated flow on the wings and fins. The off-surface flow visualization techniques showed the path of the vortex cores on the forebody and LEX as well as the LEX vortex core breakdown location. An interaction between the forebody and LEX vortices was noted. The flow over the surfaces of the vertical tail was categorized into regions of attached, unsteady, or separated flow using flow tufts

A photogrammetric solution to a particular problem

A closed-form mathematical solution to the classical photogrammetric problem is presented. Although quite general, the solution is more applicable to problems in which the image-space conjugates are very difficult to match but one of the elements of the pair is not. Additionally, observations are made that should make the solution to the general problem of automatic matching less computationally intensive. This approach was used to analyze flow visualization data for the F-18 High Alpha Research Vehicle. The conditions for this analysis were less than ideal for image-to-object-space transformation

Flight test results of riblets at supersonic speeds

A flight experiment to test and evaluate the skin friction drag characteristics of a riblet surface in turbulent flow at supersonic speeds was conducted at NASA Dryden. Riblets of groove sizes 0.0030 and 0.0013 in. were mounted on the F-104G flight test fixture. The test surfaces were surveyed with boundary layer rakes and pressure orifices to examine the boundary layer profiles and pressure distributions of the flow. Skin friction reductions caused by the riblet surface were reported based on measured differences of momentum thickness between the smooth and riblet surfaces obtained from the boundary layer data. Flight test results for the 0.0030 in. riblet show skin friction reductions of 4 to 8 % for Mach numbers ranging from 1.2 to 1.6 and Reynolds numbers ranging from 2 to 3.4 million per unit foot. The results from the 0.0013 in. riblets show skin friction reductions of 4 to 15 % for Mach 1.2 to 1.4 and Reynolds numbers ranging from 3.6 to 6 million per unit foot

Transonic flight test of a laminar flow leading edge with surface excrescences

A flight experiment, conducted at NASA Dryden Flight Research Center, investigated the effects of surface excrescences, specifically gaps and steps, on boundary-layer transition in the vicinity of a leading edge at transonic flight conditions. A natural laminar flow leading-edge model was designed for this experiment with a spanwise slot manufactured into the leading-edge model to simulate gaps and steps like those present at skin joints of small transonic aircraft wings. The leading-edge model was flown with the flight test fixture, a low-aspect ratio fin mounted beneath an F-104G aircraft. Test points were obtained over a unit Reynolds number range of 1.5 to 2.5 million/ft and a Mach number range of 0.5 to 0.8. Results for a smooth surface showed that laminar flow extended to approximately 12 in. behind the leading edge at Mach number 0.7 over a unit Reynolds number range of 1.5 to 2.0 million/ft. The maximum size of the gap-and-step configuration over which laminar flow was maintained consisted of two 0.06-in. gaps with a 0.02-in. step at a unit Reynolds number of 1.5 million/ft

Wing Leading Edge Joint Laminar Flow Tests

An F-104G aircraft at NASA's Dryden Flight Research Center has been equipped with a specially designed and instrumented test fixture to simulate surface imperfections of the type likely to be present near the leading edge on the wings of some laminar flow aircraft. The simulated imperfections consisted of five combinations of spanwise steps and gaps of various sizes. The unswept fixture yielded a pressure distribution similar to that of some laminar flow airfoils. The experiment was conducted at cruise conditions typical for business-jets and light transports: Mach numbers were in the range 0.5-0.8, and unit Reynolds numbers were 1.5-2.5 million per foot. Skin friction measurements indicated that laminar flow was often maintained for some distance downstream of the surface imperfections. Further work is needed to more precisely define transition location and to extend the experiments to swept-wing conditions and a broader range of imperfection geometries

Development of a low-aspect ratio fin for flight research experiments

A second-generation flight test fixture, developed at NASA Dryden Flight Research Center, offers a generic testbed for aerodynamic and fluid mechanics research. The new fixture, a low-aspect ratio vertical fin shape mounted on the centerline of an F-15B aircraft lower fuselage, is designed for flight research at Mach numbers up to 2.0. The new fixture is a composite structure with a modular configuration and removable components for functional flexibility. This report describes the multidisciplinary design and analysis approach used to develop the fixture. The approach integrates conservative assumptions with simple analysis techniques to minimize the time and cost associated with its development. Presented are the principal disciplines required for this effort, which include aerodynamics, structures, stability, and operational considerations. In addition, preliminary results from the first phase of flight testing are presented. Acceptable directional stability and flow quality are documented and show agreement with predictions. Future envelope expansion activities will minimize current limitations so that the fixture can be used for a wide variety of high-speed aerodynamic and fluid mechanics research experiments

Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

Background: General anaesthesia (GA) during endovascular thrombectomy has been associated with worse patient outcomes in observational studies compared with patients treated without GA. We assessed functional outcome in ischaemic stroke patients with large vessel anterior circulation occlusion undergoing endovascular thrombectomy under GA, versus thrombectomy not under GA (with or without sedation) versus standard care (ie, no thrombectomy), stratified by the use of GA versus standard care. Methods: For this meta-analysis, patient-level data were pooled from all patients included in randomised trials in PuMed published between Jan 1, 2010, and May 31, 2017, that compared endovascular thrombectomy predominantly done with stent retrievers with standard care in anterior circulation ischaemic stroke patients (HERMES Collaboration). The primary outcome was functional outcome assessed by ordinal analysis of the modified Rankin scale (mRS) at 90 days in the GA and non-GA subgroups of patients treated with endovascular therapy versus those patients treated with standard care, adjusted for baseline prognostic variables. To account for between-trial variance we used mixed-effects modelling with a random effect for trials incorporated in all models. Bias was assessed using the Cochrane method. The meta-analysis was prospectively designed, but not registered. Findings: Seven trials were identified by our search; of 1764 patients included in these trials, 871 were allocated to endovascular thrombectomy and 893 were assigned standard care. After exclusion of 74 patients (72 did not undergo the procedure and two had missing data on anaesthetic strategy), 236 (30%) of 797 patients who had endovascular procedures were treated under GA. At baseline, patients receiving GA were younger and had a shorter delay between stroke onset and randomisation but they had similar pre-treatment clinical severity compared with patients who did not have GA. Endovascular thrombectomy improved functional outcome at 3 months both in patients who had GA (adjusted common odds ratio (cOR) 1·52, 95% CI 1·09–2·11, p=0·014) and in those who did not have GA (adjusted cOR 2·33, 95% CI 1·75–3·10, p<0·0001) versus standard care. However, outcomes were significantly better for patients who did not receive GA versus those who received GA (covariate-adjusted cOR 1·53, 95% CI 1·14–2·04, p=0·0044). The risk of bias and variability between studies was assessed to be low. Interpretation: Worse outcomes after endovascular thrombectomy were associated with GA, after adjustment for baseline prognostic variables. These data support avoidance of GA whenever possible. The procedure did, however, remain effective versus standard care in patients treated under GA, indicating that treatment should not be withheld in those who require anaesthesia for medical reasons

Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance

Antimicrobial resistance (AMR) is a major threat to global health. Understanding the emergence, evolution, and transmission of individual antibiotic resistance genes (ARGs) is essential to develop sustainable strategies combatting this threat. Here, we use metagenomic sequencing to analyse ARGs in 757 sewage samples from 243 cities in 101 countries, collected from 2016 to 2019. We find regional patterns in resistomes, and these differ between subsets corresponding to drug classes and are partly driven by taxonomic variation. The genetic environments of 49 common ARGs are highly diverse, with most common ARGs carried by multiple distinct genomic contexts globally and sometimes on plasmids. Analysis of flanking sequence revealed ARG-specific patterns of dispersal limitation and global transmission. Our data furthermore suggest certain geographies are more prone to transmission events and should receive additional attention

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Background: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes in 2021, the proportion of the type 2 diabetes burden attributable to selected risk factors, and projections of diabetes prevalence through 2050. Methods: Estimates of diabetes prevalence and burden were computed in 204 countries and territories, across 25 age groups, for males and females separately and combined; these estimates comprised lost years of healthy life, measured in disability-adjusted life-years (DALYs; defined as the sum of years of life lost [YLLs] and years lived with disability [YLDs]). We used the Cause of Death Ensemble model (CODEm) approach to estimate deaths due to diabetes, incorporating 25 666 location-years of data from vital registration and verbal autopsy reports in separate total (including both type 1 and type 2 diabetes) and type-specific models. Other forms of diabetes, including gestational and monogenic diabetes, were not explicitly modelled. Total and type 1 diabetes prevalence was estimated by use of a Bayesian meta-regression modelling tool, DisMod-MR 2.1, to analyse 1527 location-years of data from the scientific literature, survey microdata, and insurance claims; type 2 diabetes estimates were computed by subtracting type 1 diabetes from total estimates. Mortality and prevalence estimates, along with standard life expectancy and disability weights, were used to calculate YLLs, YLDs, and DALYs. When appropriate, we extrapolated estimates to a hypothetical population with a standardised age structure to allow comparison in populations with different age structures. We used the comparative risk assessment framework to estimate the risk-attributable type 2 diabetes burden for 16 risk factors falling under risk categories including environmental and occupational factors, tobacco use, high alcohol use, high body-mass index (BMI), dietary factors, and low physical activity. Using a regression framework, we forecast type 1 and type 2 diabetes prevalence through 2050 with Socio-demographic Index (SDI) and high BMI as predictors, respectively. Findings: In 2021, there were 529 million (95% uncertainty interval [UI] 500-564) people living with diabetes worldwide, and the global age-standardised total diabetes prevalence was 6·1% (5·8-6·5). At the super-region level, the highest age-standardised rates were observed in north Africa and the Middle East (9·3% [8·7-9·9]) and, at the regional level, in Oceania (12·3% [11·5-13·0]). Nationally, Qatar had the world's highest age-specific prevalence of diabetes, at 76·1% (73·1-79·5) in individuals aged 75-79 years. Total diabetes prevalence-especially among older adults-primarily reflects type 2 diabetes, which in 2021 accounted for 96·0% (95·1-96·8) of diabetes cases and 95·4% (94·9-95·9) of diabetes DALYs worldwide. In 2021, 52·2% (25·5-71·8) of global type 2 diabetes DALYs were attributable to high BMI. The contribution of high BMI to type 2 diabetes DALYs rose by 24·3% (18·5-30·4) worldwide between 1990 and 2021. By 2050, more than 1·31 billion (1·22-1·39) people are projected to have diabetes, with expected age-standardised total diabetes prevalence rates greater than 10% in two super-regions: 16·8% (16·1-17·6) in north Africa and the Middle East and 11·3% (10·8-11·9) in Latin America and Caribbean. By 2050, 89 (43·6%) of 204 countries and territories will have an age-standardised rate greater than 10%. Interpretation: Diabetes remains a substantial public health issue. Type 2 diabetes, which makes up the bulk of diabetes cases, is largely preventable and, in some cases, potentially reversible if identified and managed early in the disease course. However, all evidence indicates that diabetes prevalence is increasing worldwide, primarily due to a rise in obesity caused by multiple factors. Preventing and controlling type 2 diabetes remains an ongoing challenge. It is essential to better understand disparities in risk factor profiles and diabetes burden across populations, to inform strategies to successfully control diabetes risk factors within the context of multiple and complex drivers. Funding: Bill & Melinda Gates Foundation